C M Bidwell & Associates Ltd. bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The fund bought 2,874 shares of the company’s stock, valued at approximately $683,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CAH. Investors Research Corp acquired a new stake in Cardinal Health during the second quarter worth about $29,000. University of Texas Texas AM Investment Management Co. acquired a new position in Cardinal Health in the 4th quarter valued at about $26,000. Allied Private Wealth LLC purchased a new stake in shares of Cardinal Health in the 2nd quarter valued at approximately $30,000. Bank of Jackson Hole Trust purchased a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $27,000. Finally, Indiana Trust & Investment Management Co acquired a new stake in shares of Cardinal Health during the 1st quarter worth approximately $29,000. Institutional investors and hedge funds own 87.17% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Robert W. Baird raised their price objective on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 12th. William Blair assumed coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating on the stock. UBS Group increased their target price on shares of Cardinal Health from $274.00 to $280.00 and gave the stock a “buy” rating in a research note on Wednesday, August 12th. Mizuho lifted their price target on shares of Cardinal Health from $240.00 to $250.00 and gave the company an “outperform” rating in a research report on Wednesday, August 12th. Finally, Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $266.56.
Trending Headlines about Cardinal Health
Here are the key news stories impacting Cardinal Health this week:
- Positive Sentiment: Royal Bank of Canada initiated coverage with an “outperform” rating and a $276 price target, implying meaningful upside from recent trading levels. RBC cited Cardinal Health’s higher-margin services as a potential earnings-growth driver. RBC initiates coverage of Cardinal Health
- Positive Sentiment: Wall Street remains broadly constructive, with 16 analysts rating CAH a Buy and three assigning a Hold rating. The consensus rating is “Moderate Buy,” with an average price target of approximately $266.56. Zacks also identified Cardinal Health as a potentially attractive long-term value stock. Zacks value-stock analysis
- Positive Sentiment: Cardinal Health’s latest quarter delivered adjusted earnings per share of $2.91, well above the $2.42 consensus estimate, while revenue increased 5.8% year over year. Fiscal 2027 EPS guidance of $12.40–$12.60 supports the longer-term earnings case.
- Neutral Sentiment: The company declared a quarterly dividend of $0.5158 per share, equivalent to $2.06 annually and a yield of about 0.9%. The payout offers modest income support but is unlikely to be a major near-term catalyst.
- Negative Sentiment: Several executives sold sizable holdings around $235–$237 per share. CEO Jason Hollar sold 124,529 shares worth about $29.4 million, while other executive and insider sales—including those by Deborah Weitzman, Stephen Mason, Michelle Greene, Jessica Mayer and Mary Scherer—totaled roughly $20 million more. The concentrated selling and substantial reductions in insider ownership may encourage profit-taking concerns after CAH’s strong advance. Cardinal Health insider sales
- Negative Sentiment: Investors may also question the durability of the latest earnings beat because part of the improvement reportedly reflected a one-time tariff refund, potentially limiting the stock’s upside if recurring earnings growth does not match expectations. Cardinal Health earnings analysis
Cardinal Health Price Performance
NYSE CAH opened at $229.48 on Friday. The firm’s fifty day moving average price is $232.02 and its 200 day moving average price is $217.86. Cardinal Health, Inc. has a 12 month low of $145.87 and a 12 month high of $258.30. The company has a market capitalization of $53.37 billion, a price-to-earnings ratio of 31.74, a price-to-earnings-growth ratio of 1.22 and a beta of 0.49.
Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The firm had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The business’s revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.
Cardinal Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.
Insider Buying and Selling at Cardinal Health
In other Cardinal Health news, CEO Stephen M. Mason sold 35,000 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total value of $8,274,000.00. Following the sale, the chief executive officer directly owned 18,061 shares of the company’s stock, valued at approximately $4,269,620.40. This trade represents a 65.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Deborah Weitzman sold 7,354 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the sale, the chief executive officer directly owned 77,901 shares of the company’s stock, valued at $18,341,790.45. This represents a 8.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 210,271 shares of company stock worth $49,626,657. Insiders own 0.12% of the company’s stock.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
